Literature DB >> 25271477

Haemophilus ducreyi associated with skin ulcers among children, Solomon Islands.

Michael Marks, Kai-Hua Chi, Ventis Vahi, Allan Pillay, Oliver Sokana, Alex Pavluck, David C Mabey, Cheng Y Chen, Anthony W Solomon.   

Abstract

During a survey of yaws prevalence in the Solomon Islands, we collected samples from skin ulcers of 41 children. Using PCR, we identified Haemophilus ducreyi infection in 13 (32%) children. PCR-positive and PCR-negative ulcers were phenotypically indistinguishable. Emergence of H. ducreyi as a cause of nongenital ulcers may affect the World Health Organization's yaws eradication program.

Entities:  

Mesh:

Year:  2014        PMID: 25271477      PMCID: PMC4193279          DOI: 10.3201/eid2010.140573

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Bacterial ulcerative skin diseases are a common cause of illness in the developing world (). Some of these diseases, including Buruli ulcer, caused by Mycobacterium ulcerans, and yaws, caused by Treponema pallidum subspecies pertenue, occur only in tropical and subtropical climates. Yaws is endemic in the Solomon Islands, where ≈15,000 cases per year are reported (). In 2012, the World Health Organization (WHO) launched a worldwide yaws eradication program based on treatment by mass distribution of azithromycin and monitoring for skin ulcers (). Reports suggest that Haemophilus ducreyi, the causative organism of chancroid, a sexually transmitted infection, may be associated with nonsexual transmission of nongenital ulcers of the skin in persons from the Pacific region (,). If this organism is a common cause of skin ulcers in the region, this factor has crucial implications for the yaws eradication strategy. PCR has been shown to be highly sensitive and specific for diagnosing chancroid (). We used real-time PCR to detect H. ducreyi in skin ulcer samples collected during a survey for yaws in the Solomon Islands.

The Study

We conducted a cross-sectional survey for yaws in the Western Province and Choiseul Province of the Solomon Islands in 2013. In each province, we chose 25 clusters using a probability-proportionate-to-size method. In each cluster, we selected 30 houses by random sampling; children 5 to 14 years of age living in those houses were invited to participate. Informed written consent was obtained from the children’s parents. Children underwent standardized examination. We recorded location, classification, and duration of skin lesions and yaws treatment history using the LINKS system (, http://www.linkssystem.org/). Lesions were classified by using the WHO pictorial grading scheme for yaws (). Tenderness was classified based on reports by children. Blood samples were collected from all children. For children with exudative skin lesions, a sample for PCR was collected by rolling a sterile cotton-tipped swab across the lesion and placing it in a cryotube pre-filled with 1.2 mL of AssayAssure solution (Thermo Fisher Scientific, Waltham, MA, USA). Samples were transferred to Honiara National Referral Hospital within 5 days and stored at −20°C. Serum samples were placed on dry ice and shipped to the London School of Hygiene & Tropical Medicine and lesion samples to the US Centers for Disease Control and Prevention. Serum samples were tested by using T. pallidum particle agglutination (Mast Diagnostics, Merseyside, UK) at the London School of Hygiene & Tropical Medicine. For samples with a positive T. pallidum particle agglutination, a rapid plasma regain test was performed (Deben Diagnostics, Ipswich, UK). DNA was extracted from lesion samples in a CDC laboratory by using iPrep PureLink gDNA blood kits and the iPrep purification instrument (Life Technologies, Grand Island, NY, USA). A real-time duplex PCR targeting the DNA polymerase I gene (polA, tp0105) of pathogenic treponemes (which detects all 3 T. pallidum subspecies) and the human RNase P gene (to monitor for PCR inhibition) was performed by using a Rotor-Gene-Q real-time PCR instrument (QIAGEN Inc., Valencia, CA, USA) (). Negative (no-template) control and positive controls for T. pallidum DNA were included in each PCR run. Considering reports of H. ducreyi and the occurrence of M. ulcerans in Papua New Guinea, immediately north of the Solomon Islands, we performed a second duplex real-time PCR for M. ulcerans and H. ducreyi on all samples by using previously validated targets (,). For the purpose of analysis, lesions were classified as acute (<4 weeks) or chronic (>4 weeks). A rapid plasma regain titer ≥1/4 was considered positive. Fisher exact test was used to compare characteristics of patients whose lesions contained H. ducreyi with patients whose lesions did not contain H. ducreyi. Analyses were performed by using STATA 13.1 (http://www.stata.com/). During the survey, 1,497 children were examined. Samples for PCR were collected from 41 children who had exudative lesions (19 male, median age 8 years). Twenty-two children had ulcerative lesions from which a sample could not be collected. Twelve (29.3%) children had positive results for yaws from serologic testing, but no DNA evidence of T. pallidum subsp. pertenue or M. ulcerans, causative organisms of yaws and Buruli ulcer, respectively, was detected in any sample. H. ducreyi DNA was amplified from 13 (32%) samples (Figure). PCR inhibitors were not found in any samples. Clinical data were incomplete for 2 participants. There were no notable differences in the recorded characteristics of skin lesions or in the serologic status of patients in whose ulcers H ducreyi DNA was found compared with those in which H ducreyi was not found (Table).
Figure

Example of lesion from which sample was obtained and Haemophilus ducreyi DNA was amplified, Solomon Islands, 2013. Photograph ©2014 Michael Marks.

Table

Comparison of skin ulcer samples from 41 patients tested for Haemophilus ducreyi, Solomon Islands, 2013*

CharacteristicNo. (%) samples tested for H. ducreyi by real-time-PCR, 95% CI
p value
Positive, n = 13Negative, n = 28
Male sex8 (62), 32%–86%10 (36), 19%–56%0.179
Location of lesion on leg12 (92), 64%–99%21 (96), 80%–99%0.561
Duration <4 weeks7 (54), 25%–81%14 (54), 33%–73%0.632
Painful lesion8 (62), 32%–86%17 (65), 44%–83%0.542
Sample TPPA-positive6 (46), 19%–75%17 (61), 41%–78%0.503
Sample TPPA- and RPR-positive5 (38), 14%–68%7 (25), 11%–45%0.469

*TPPA, Treponema pallidum particle agglutination; RPR, rapid plasma regain test.

Example of lesion from which sample was obtained and Haemophilus ducreyi DNA was amplified, Solomon Islands, 2013. Photograph ©2014 Michael Marks. *TPPA, Treponema pallidum particle agglutination; RPR, rapid plasma regain test.

Conclusions

H. ducreyi is frequently present in skin ulcers of children in the Solomon Islands, and lesions containing H ducreyi DNA were similar in location, duration, and tenderness to lesions in which H ducreyi was not found. Papua New Guinea reported a similar finding (). Experimental models of chancroid have demonstrated that injection of H. ducreyi into the epidermis and dermis causes nongenital skin disease, suggesting that H. ducreyi may be the cause of some ulcers in our survey (). Similar to results for experimental models, H. ducreyi DNA was found more frequently in samples collected from boys (8/13; p = 0.179), although this difference was not statistically significant. It is possible that the difficulty of collecting samples for molecular testing, the lack of facilities to enable collection of samples for culture in affected areas, and the precise culture requirements of H. ducreyi have notably delayed recognition of this association (). Lesions associated with H. ducreyi were found in patients with positive and negative serologic test results for T. pallidum subsp. pertenue. It is likely that patients with positive serologic test results represent latent yaws with an alternative etiologic agent causing the current lesion. The possibility that there are alternative causes of childhood skin ulcers in the Pacific region could have implications for WHO’s yaws eradication strategy, which is based on detection of suspected clinical cases. Although azithromycin is effective in treating genital strains of H. ducreyi and experimental nongenital lesions (), further studies are needed to confirm efficacy in nongenital lesions in a clinical setting. The emerging data suggest that surveillance strategies should routinely require molecular diagnostics. A causative agent was not identified in a large proportion of lesion samples. A variety of possible reasons exist for this, including the fact that some lesions were noninfectious, such as insect bites, some numbers of organisms were below current limits of detection of real-time-PCR, or that other organisms, such as staphylococci, for which PCR was not performed, caused these lesions. The sample collection/transport media and PCR assays we used varied from those used by Mitjà et al (), but it is unclear to what extent this effected our results. A single sample was collected per patient, but several patients (n = 8, 19.5%) had >1 skin lesion. Swabbing every lesion may have increased the diagnostic yield for H. ducreyi and/or T. pallidum subsp. pertenue. Further studies to explore causes of skin ulcers in this community are needed to better inform disease control efforts. Because it was not anticipated that H. ducreyi DNA would be found in nongenital skin lesions, we did not prospectively collect data on regional lymphadenopathy; however, we did not notice marked lymphadenopathy or bubo formation. Collection of samples for culture and sequencing of the H. ducreyi genome are needed to inform our understanding of relatedness of these strains to genital strains. This study has 2 main limitations. First, the number of samples tested was small. Second, lesion samples were tested for only 3 organisms, raising the possibility that other organisms caused a large proportion of skin ulcers. Despite these limitations, this study clearly demonstrates that H. ducreyi is frequently present in childhood skin ulcers in this yaws-endemic community. Further studies of the epidemiology, microbiology, and response to treatment for this newly described pathogen–disease association are required.
  13 in total

Review 1.  Yaws.

Authors:  Oriol Mitjà; Kingsley Asiedu; David Mabey
Journal:  Lancet       Date:  2013-02-13       Impact factor: 79.321

2.  Transport media for Haemophilus ducreyi.

Authors:  Y Dangor; F Radebe; R C Ballard
Journal:  Sex Transm Dis       Date:  1993 Jan-Feb       Impact factor: 2.830

3.  Laboratory-confirmed case of yaws in a 10-year-old boy from the Republic of the Congo.

Authors:  Allan Pillay; Cheng-Yen Chen; Mary G Reynolds; Jean V Mombouli; Arnold C Castro; Davy Louvouezo; Bret Steiner; Ronald C Ballard
Journal:  J Clin Microbiol       Date:  2011-09-14       Impact factor: 5.948

4.  Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2 from genital ulcers.

Authors:  K A Orle; C A Gates; D H Martin; B A Body; J B Weiss
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

5.  Cumulative experience with Haemophilus ducreyi 35000 in the human model of experimental infection.

Authors:  J A Al-Tawfiq; J Harezlak; B P Katz; S M Spinola
Journal:  Sex Transm Dis       Date:  2000-02       Impact factor: 2.830

Review 6.  Tropical dermatology: bacterial tropical diseases.

Authors:  Omar Lupi; Vandana Madkan; Stephen K Tyring
Journal:  J Am Acad Dermatol       Date:  2006-04       Impact factor: 11.527

7.  Haemophilus ducreyi causing chronic skin ulceration in children visiting Samoa.

Authors:  James E Ussher; Elizabeth Wilson; Silvana Campanella; Susan L Taylor; Sally A Roberts
Journal:  Clin Infect Dis       Date:  2007-04-04       Impact factor: 9.079

8.  Development and application of real-time PCR assay for quantification of Mycobacterium ulcerans DNA.

Authors:  S Rondini; E Mensah-Quainoo; H Troll; T Bodmer; G Pluschke
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

9.  Haemophilus ducreyi as a cause of skin ulcers in children from a yaws-endemic area of Papua New Guinea: a prospective cohort study.

Authors:  Oriol Mitjà; Sheila A Lukehart; Gideon Pokowas; Penias Moses; August Kapa; Charmie Godornes; Jennifer Robson; Sarah Cherian; Wendy Houinei; Walter Kazadi; Peter Siba; Elisa de Lazzari; Quique Bassat
Journal:  Lancet Glob Health       Date:  2014-03-27       Impact factor: 26.763

10.  Electronic data capture tools for global health programs: evolution of LINKS, an Android-, web-based system.

Authors:  Alex Pavluck; Brian Chu; Rebecca Mann Flueckiger; Eric Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2014-04-10
View more
  40 in total

1.  A Class I Haemophilus ducreyi Strain Containing a Class II hgbA Allele Is Partially Attenuated in Humans: Implications for HgbA Vaccine Efficacy Trials.

Authors:  Isabelle Leduc; Kate R Fortney; Diane M Janowicz; Beth Zwickl; Sheila Ellinger; Barry P Katz; Huaiying Lin; Qunfeng Dong; Stanley M Spinola
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

Review 2.  On the in vivo significance of bacterial resistance to antimicrobial peptides.

Authors:  Margaret E Bauer; William M Shafer
Journal:  Biochim Biophys Acta       Date:  2015-02-18

3.  Genes Differentially Expressed by Haemophilus ducreyi during Anaerobic Growth Significantly Overlap Those Differentially Expressed during Experimental Infection of Human Volunteers.

Authors:  Julie A Brothwell; Stanley M Spinola
Journal:  J Bacteriol       Date:  2022-04-04       Impact factor: 3.476

4.  Host Polymorphisms in TLR9 and IL10 Are Associated With the Outcomes of Experimental Haemophilus ducreyi Infection in Human Volunteers.

Authors:  Martin Singer; Wei Li; Servaas A Morré; Sander Ouburg; Stanley M Spinola
Journal:  J Infect Dis       Date:  2016-04-27       Impact factor: 5.226

5.  DksA and (p)ppGpp have unique and overlapping contributions to Haemophilus ducreyi pathogenesis in humans.

Authors:  Concerta L Holley; Xinjun Zhang; Kate R Fortney; Sheila Ellinger; Paula Johnson; Beth Baker; Yunlong Liu; Diane M Janowicz; Barry P Katz; Robert S Munson; Stanley M Spinola
Journal:  Infect Immun       Date:  2015-06-08       Impact factor: 3.441

6.  Haemophilus ducreyi Seeks Alternative Carbon Sources and Adapts to Nutrient Stress and Anaerobiosis during Experimental Infection of Human Volunteers.

Authors:  Dharanesh Gangaiah; Xinjun Zhang; Beth Baker; Kate R Fortney; Hongyu Gao; Concerta L Holley; Robert S Munson; Yunlong Liu; Stanley M Spinola
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

7.  Immunization with the Haemophilus ducreyi trimeric autotransporter adhesin DsrA with alum, CpG or imiquimod generates a persistent humoral immune response that recognizes the bacterial surface.

Authors:  Melissa Samo; Neelima R Choudhary; Kristina J Riebe; Ivo Shterev; Herman F Staats; Gregory D Sempowski; Isabelle Leduc
Journal:  Vaccine       Date:  2016-01-24       Impact factor: 3.641

8.  Failure of PCR to Detect Treponema pallidum ssp. pertenue DNA in Blood in Latent Yaws.

Authors:  Michael Marks; Samantha Katz; Kai-Hua Chi; Ventis Vahi; Yongcheng Sun; David C Mabey; Anthony W Solomon; Cheng Y Chen; Allan Pillay
Journal:  PLoS Negl Trop Dis       Date:  2015-06-30

Review 9.  Challenges and key research questions for yaws eradication.

Authors:  Michael Marks; Oriol Mitjà; Lasse S Vestergaard; Allan Pillay; Sascha Knauf; Cheng-Yen Chen; Quique Bassat; Diana L Martin; David Fegan; Fasihah Taleo; Jacob Kool; Sheila Lukehart; Paul M Emerson; Anthony W Solomon; Tun Ye; Ronald C Ballard; David C W Mabey; Kingsley B Asiedu
Journal:  Lancet Infect Dis       Date:  2015-09-08       Impact factor: 25.071

10.  Multiple Class I and Class II Haemophilus ducreyi Strains Cause Cutaneous Ulcers in Children on an Endemic Island.

Authors:  Jacob C Grant; Camila González-Beiras; Kristen M Amick; Kate R Fortney; Dharanesh Gangaiah; Tricia L Humphreys; Oriol Mitjà; Ana Abecasis; Stanley M Spinola
Journal:  Clin Infect Dis       Date:  2018-11-13       Impact factor: 20.999

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.